重大事件
即時報告
8-K
2026-05-28
Alto Neuroscience提交8-K 涉董事或高層人事變動 投資者需關注後續細節
AI 繁中摘要
Alto Neuroscience, Inc. 提交了一份 Form 8-K 申報文件，報告日期為 2026年5月27日，並於2026年5月28日向美國證監會提交。📄
是次申報主要涉及 **Item 5.02**：董事或特定高級職員的離職、選舉、任命，以及相關補償安排。由於申報文件僅提供基本封面資訊，未有披露具體的人事變動或薪酬調整細節，投資者需參閱完整申報文本以獲取最新動態。🕵️♂️
公司為專注藥物製劑（SIC 2834）的生物科技企業，總部位於加州山景城。此次8-K屬例行性揭露，反映企業管治層面的即時更新，對股東而言，後續如有重大變動（如CEO或CFO變更、關鍵薪酬計劃修改）將直接影響公司治理與營運穩定性，建議密切留意後續補充文件。💊📊
展開英文正文
EDGAR Filing Documents for 0001999480-26-000016 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001999480-26-000016 Filing Date 2026-05-28 Accepted 2026-05-28 08:18:14 Documents 11 Period of Report 2026-05-27 Items Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Interactive Data Document Format Files Seq Description Document Type Size 1 8-K alto-20260527.htm iXBRL 8-K 35417 Complete submission text file 0001999480-26-000016.txt 156183 Data Files Seq Description Document Type Size 2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alto-20260527.xsd EX-101.SCH 1809 3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alto-20260527_lab.xml EX-101.LAB 22530 4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alto-20260527_pre.xml EX-101.PRE 13061 14 EXTRACTED XBRL INSTANCE DOCUMENT alto-20260527_htm.xml XML 2826 Mailing Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041 Business Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041 773-255-5012 Alto Neuroscience, Inc. (Filer) CIK: 0001999480 (see all company filings) EIN.: 834210124 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-41944 | Film No.: 261028648 SIC: 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)